Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Sino-American East China Pharmaceutical
Hangzhou, Zhejiang, Chinaeastchinapharm.com ↗
- Ownership
- Private
- Employees
- ~10000
- Development stage
- Other
01
Overview
Huadong Medicine has a broad commercial portfolio with leading positions in immunosuppressants, organ transplantation drugs, diabetes therapies, oncology drugs including ADCs and cell therapies. Recent clinical milestones include FDA approval of ELAHERE™ for ovarian cancer in partnership with ImmunoGen; domestic approval of liraglutide injection for type 2 diabetes; IND-stage siRNA program targeting AGT for hypertension; multiple ongoing late-stage trials in oncology and metabolic disease.
- Therapeutic areas
- CardiovascularImmunologyEndocrinologyOncology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateCell therapyRNA therapy
- Industry
- Biotech
02
Partnerships
ImmunoGen Inc. (ADC development/commercialization)SynerK PharmaTech (“SNK‑2726” siRNA program)HeidelbergPharma AG (“ADC” technology investment/cooperation)Keji Pharmaceutical (“Zewaukee Oronse” CAR-T product commercialization in mainland China)
Beyond the preview
Go deeper on Hangzhou Sino-American East China Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hangzhou Sino-American East China Pharmaceutical.